GB201021696D0 - Ingestible formulations for use in acute tryptophan depletion, acute tryptophan loading, and like tests and in the treatment of pyschotic and manic disorders - Google Patents

Ingestible formulations for use in acute tryptophan depletion, acute tryptophan loading, and like tests and in the treatment of pyschotic and manic disorders

Info

Publication number
GB201021696D0
GB201021696D0 GBGB1021696.8A GB201021696A GB201021696D0 GB 201021696 D0 GB201021696 D0 GB 201021696D0 GB 201021696 A GB201021696 A GB 201021696A GB 201021696 D0 GB201021696 D0 GB 201021696D0
Authority
GB
United Kingdom
Prior art keywords
acute
acute tryptophan
pyschotic
tests
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1021696.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GBGB1021696.8A priority Critical patent/GB201021696D0/en
Publication of GB201021696D0 publication Critical patent/GB201021696D0/en
Priority to PCT/GB2011/051229 priority patent/WO2012004585A1/en
Ceased legal-status Critical Current

Links

GBGB1021696.8A 2010-07-09 2010-12-22 Ingestible formulations for use in acute tryptophan depletion, acute tryptophan loading, and like tests and in the treatment of pyschotic and manic disorders Ceased GB201021696D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1021696.8A GB201021696D0 (en) 2010-12-22 2010-12-22 Ingestible formulations for use in acute tryptophan depletion, acute tryptophan loading, and like tests and in the treatment of pyschotic and manic disorders
PCT/GB2011/051229 WO2012004585A1 (en) 2010-07-09 2011-06-29 Ingestible formulation comprising glycomacropeptide and at least one of tryptophan, tyrosine and phenylalanine and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1021696.8A GB201021696D0 (en) 2010-12-22 2010-12-22 Ingestible formulations for use in acute tryptophan depletion, acute tryptophan loading, and like tests and in the treatment of pyschotic and manic disorders

Publications (1)

Publication Number Publication Date
GB201021696D0 true GB201021696D0 (en) 2011-02-02

Family

ID=43598774

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1021696.8A Ceased GB201021696D0 (en) 2010-07-09 2010-12-22 Ingestible formulations for use in acute tryptophan depletion, acute tryptophan loading, and like tests and in the treatment of pyschotic and manic disorders

Country Status (1)

Country Link
GB (1) GB201021696D0 (en)

Similar Documents

Publication Publication Date Title
HRP20181364T1 (en) Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof
ZA201205683B (en) Probiotic composition for use in the treatment of bowel inflammation
IL211952A0 (en) Implantable device for the delivery of risperidone and methods of use thereof
IL223241A0 (en) Cysteamine derivatives and their use in the treatment of nash
HK1169573A1 (en) Applicator device for cosmetic and or medical use
ZA201304638B (en) Composition for use in the prevention and /or treatment of skin condition and skin diseases.
HK1168091A1 (en) Oxazine derivatives and their use in the treatment of neurological disorders
IL220661A0 (en) Beta-carbolines for use in the treatment of hearing loss and vertigo
EP2651894A4 (en) Thiosemicarbazone compounds and use in the treatment of cancer
HK1164369A1 (en) Preparation of microvesicle-sirna composition and use of the same in aids treatment
GB0920258D0 (en) New medical agents and use thereof
EP2390375A4 (en) Alloy for medical use and medical device
HK1193379A1 (en) Remedial composition and treatment methods
HK1173181A1 (en) Medicament and agent for treating and diagnosing immune disorders and their use
ZA201209298B (en) Hydroxyalkyl benzyl pyrazoles,and use thereof for the treatment of hyperproliferative and angiogenic diseases
EP2361317A4 (en) Use of eif3m for the diagnosis and treatment of cancer
IL222482A0 (en) Methods and compositions for the treatment of fluid accumulation in and/or under the retina
HUE047515T2 (en) N-substituted benzenepropanamides for use in the treatment of pain and inflammation
HK1214771A1 (en) Formulations for use in the treatment of skin conditions
GB201021696D0 (en) Ingestible formulations for use in acute tryptophan depletion, acute tryptophan loading, and like tests and in the treatment of pyschotic and manic disorders
HK1136303A1 (en) Formulation and use of ergosta-7,22-dien-3-ol -722--3-
GB201011565D0 (en) Ingestible formulations for use in acute tryptophan depletion, acute tryptophan loading, and like tests.
IL243237A0 (en) Methods and compositions for the treatment of fluid accumulation in and/ or under the retina
HU1000356D0 (en) Quinoxaline derivatives and their use for the treatment of mycobacterial infections
PT2389936E (en) Aminaphtone for use in the treatment and/or prevention of migraine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)